OrbiMed Advisors »

Rapport Therapeutics shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.2M 77k 41.67

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Eli Lilly & Co. (LLY)
Mbx Biosciences (MBX)
Sinovac Biotech SHS
Astrazeneca Ord (AZN)
Structure Therapeutics Sponsored Ads (GPCR)
Sionna Therapeutics (SION)
Corvus Pharmaceuticals (CRVS)
Arrivent Biopharma (AVBP)
Abivax Sa Sponsored Ads Call Option (ABVX)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Merck & Co (MRK)
Uniqure Nv SHS (QURE)

View all positions for OrbiMed Advisors

Top funds holding Rapport Therapeutics

FMR
TRV GP V
Arch Venture Corp
Capital Research and Management Company - Division 3
Goldman Sachs Group
BlackRock
Cormorant Asset Management
Sofinnova Ventures
Johnson & Johnson
Polar Capital Holdings
Baker Bros. Advisors
Vanguard Capital Management
Trv Gp Vi
T. Rowe Price Associates
Geode Capital Management

View all funds holding Rapport Therapeutics